Antibodies to Epstein-Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma

International Journal of Cancer

Volumn 91, Issue 5, 2001, Pages 692-697

  Connolly, Yvonne ^a,b   Littler, Edward ^a   Sun, Ning ^a   Chen, Xiaoyi ^a   Huang, Pei Chun ^a,b   Stacey, Simon N ^a,b   Arrand, John R ^a,b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Chronic nasopharyngitis; Epstein Barr virus; IgA; Nasopharyngeal carcinoma; Serology; Thymidine kinase

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; THYMIDINE KINASE; TUMOR MARKER; VIRUS ANTIGEN;

ANTIBODY TITER; ARTICLE; CANCER RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOPHARYNGITIS; SERODIAGNOSIS; VIRUS CAPSID; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES; BACULOVIRIDAE; CARCINOMA; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; INSECTS; MICROSCOPY, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNGITIS; PILOT PROJECTS; RISK FACTORS; THYMIDINE KINASE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035283742     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1108>3.0.CO;2-G     Document Type: Article

References (24)

1. Epstein-Barr virus and nasopharyngeal carcinoma
2. Epstein-Barr virus
3. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma
4. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
5. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups
6. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography
7. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan
8. Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma
9. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins
10. Enzyme-linked immunosorbent assay (ELISA) for IgA and IgG antibodies to Epstein-Barr-virus ribonucleotide reductase in patients with nasopharyngeal carcinoma
11. Purified recombinant EBV desoxyribonuclease in serological diagnosis of nasopharyngeal carcinoma
12. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma
13. Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr virus coded thymidine kinase expressed in Escherichia coli
14. p36C: An improved baculovirus expression vector for producing high levels of mature recombinant proteins
15. High-level expression of the Epstein-Barr virus alkaline deoxyribonuclease using a recombinant baculovirus: Application to the diagnosis of nasopharyngeal carcinoma
16. Murine gammaherpesvirus (MHV-68) encodes homologues of thymidine kinase and glycoprotein H: Sequence, expression and characterization of pyrimidine kinase activity
17. A report of NPC investigation in 15 farms and factories of Zhanjiang farmer system in western Guangdong province
18. Immunological conservation between Epstein-Barr virus and herpes simplex virus
19. Serological survey of nasopharyngeal carcinoma in 21 cities of south China
20. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16 associated invasive cervical cancer
21. Identification of an Epstein-Barr virus-coded thymidine kinase
22. The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies
23. Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinoma